New solution for 5ᵗʰ metatarsal deformities further broadens portfolio and provides access to incremental surgical procedures
PONTE VEDRA, Fla., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company with the goal of being the recognized leader in the surgical treatment of bunions and other foot & ankle conditions, today announced the successful completion of the first cases utilizing its Tailorplasty™ MIS Tailor’s Bunion Correction System.
The Tailorplasty™ procedure extends Treace's instrumented bunion correction platform to tailor's bunions, or "bunionettes” which are painful deformities of the fifth metatarsal estimated to affect approximately 5-10% of the adult population.
Tailorplasty™ provides instrument-guided surgical correction of the bunionette deformity through a MIS (
